ZMB-15103-51510
1 vaccination
1 coded response
7 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 953 / CA
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-28
Registered in v-safe
- 2021-03-28
- 2021-04-02
- 2021-04-09
- 2021-04-19
- 2021-04-23
-
2021-06-11
Survey response — 3 months, dose 1MedDRA: Lacrimation increased, Rhinorrhoea, Sneezing — Feeling: FairFree text: Sneezing, runny nose, watery eyesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Janssen/Johnson & Johnson |
Free text
Release 9 — 3 months, dose 1
Symptoms: Sneezing, runny nose, watery eyes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Lacrimation increased | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release